Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

928 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy.
Felip E, Rojo F, Reck M, Heller A, Klughammer B, Sala G, Cedres S, Peralta S, Maacke H, Foernzler D, Parera M, Möcks J, Saura C, Gatzemeier U, Baselga J. Felip E, et al. Among authors: heller a. Clin Cancer Res. 2008 Jun 15;14(12):3867-74. doi: 10.1158/1078-0432.CCR-07-5186. Clin Cancer Res. 2008. PMID: 18559607 Clinical Trial.
Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-18F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model.
Schelhaas S, Wachsmuth L, Hermann S, Rieder N, Heller A, Heinzmann K, Honess DJ, Smith DM, Fricke IB, Just N, Doblas S, Sinkus R, Döring C, Schäfers KP, Griffiths JR, Faber C, Schneider R, Aboagye EO, Jacobs AH. Schelhaas S, et al. Among authors: heller a. J Nucl Med. 2018 Jul;59(7):1063-1069. doi: 10.2967/jnumed.117.206250. Epub 2018 Feb 23. J Nucl Med. 2018. PMID: 29476002 Free article.
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A, Davydov II, Schwalie PC, Serrano-Serrano ML, Heller A, Staedler N, Ferreira CS, Dietmann G, Klaman I, Valdeolivas A, Korski K, Cannarile MA. Roller A, et al. Among authors: heller a. J Immunother Cancer. 2024 Apr 22;12(4):e008185. doi: 10.1136/jitc-2023-008185. J Immunother Cancer. 2024. PMID: 38649280 Free PMC article.
Development of bispecific molecules for the in situ detection of protein-protein interactions and protein phosphorylation.
van Dieck J, Schmid V, Heindl D, Dziadek S, Schraeml M, Gerg M, Massoner P, Engel AM, Tiefenthaler G, Vural S, Stritt S, Tetzlaff F, Soukupova M, Kopetzki E, Bossenmaier B, Thomas M, Klein C, Mertens A, Heller A, Tacke M. van Dieck J, et al. Among authors: heller a. Chem Biol. 2014 Mar 20;21(3):357-68. doi: 10.1016/j.chembiol.2013.12.018. Epub 2014 Feb 13. Chem Biol. 2014. PMID: 24529991
Fishy business in Seattle: Salmon mislabeling fraud in sushi restaurants vs grocery stores.
Garcia JL, Gaspar YA, Djekoundade A, Dalere M, Al-Awadi AA, Allossogbe M, Allossogbe TCP, Aparicio IS, Buller HN, Cadelina HBF, Camarillo IK, Case K, Dean AE, Dean SM, DeJong JF, Delgado E, Dupar RJ, Ely EN, Ewing MC, Filli DN, Fleming SE, Garrett MR, Graves BP, Hafez MM, Hanson WP, Heller AD, Hernandez AJ, Horton EK, Jancola EG, Keith LA, Knoke MJ, Larkin JD, Marineau AG, Martin-Ortiz F, Mayer OL, Mendoza YM, Nalivayko PV, Nguyen N, Nguyen ET, Nguyen H, Ovenell GL, Paw LG, Raymond SR, Redzic JJ, Rice MT, Rodrigo AT, Savell JM, Sheirbon BR, Torres DS, Warrick KA, Long ES, Nelson TA, Delgado T. Garcia JL, et al. Among authors: heller ad. PLoS One. 2024 Nov 6;19(11):e0311522. doi: 10.1371/journal.pone.0311522. eCollection 2024. PLoS One. 2024. PMID: 39504310 Free PMC article.
928 results